Mounjaro (Tirzepatide) KwikPen is a prescription medication used for managing type 2 diabetes.
It is administered as a subcutaneous injection and is designed to help improve blood sugar control.
Benefits
<ol><li><p>Combination Therapy:</p><ul><li>Mounjaro is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.</li><li>It helps enhance insulin secretion and suppress glucagon release, improving blood sugar control.</li></ul></li><li><p>Convenient Dosage Form:</p><ul><li>Comes in a pre-filled pen, making it easy to use.</li><li>Each pen contains 12.5mg of tirzepatide in 0.6ml solution, providing a precise dose.</li></ul></li><li><p>Flexible Dosing:</p><ul><li>Typically administered once weekly.</li><li>Dosing can be adjusted based on patient response and tolerance.</li></ul></li></ol>
